LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
PHIN
PHINIA Inc.
PHIN has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PHIN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
PHIN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PHIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $72.51 | — |
| Current | 15x | $72.51 | — |
| Cheap | 19x | $92.38 | +27% |
| Fair | 22x | $110 | +52% |
| Expensive | 25x | $121 | +67% |
Historical ranges are pointers, not guarantees.
PHIN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PHIN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PHIN, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PHIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.94 | +40% |
| Q3 2026 | $4.95 | +122% |
| Q2 2026 | $3.48 | +34% |
| Q1 2026 | $3.57 | +102% |
| Q4 2025 | $3.24 | +84% |
| Q3 2025 | $2.23 | -4.3% |
| Q2 2025 | $2.60 | +39% |
| Q1 2025 | $1.77 | -23% |
| Q4 2024 | $1.76 | -15% |
PHIN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PHIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PHIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $912M | +0.4% |
| Q2 2026 | $940M | +5.6% |
| Q1 2026 | $878M | +10% |
| Q4 2025 | $889M | +6.7% |
| Q3 2025 | $908M | +8.2% |
| Q2 2025 | $890M | +2.5% |
| Q1 2025 | $796M | -7.8% |
| Q4 2024 | $833M | -5.6% |
PHIN's revenue has grown year over year for six quarters in a row: $912M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.2% | +5.5 points |
| Q2 2026 | 8.5% | -1.5 points |
| Q1 2026 | 7.9% | +0.1 points |
| Q4 2025 | 7.8% | +1.6 points |
| Q3 2025 | 3.7% | -4.1 points |
| Q2 2025 | 10% | +1.8 points |
| Q1 2025 | 7.8% | -0.4 points |
| Q4 2024 | 6.1% | -3.1 points |
PHIN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PHIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $70M | -25% |
| Q2 2026 | $69M | +200% |
| Q1 2026 | $21M | +320% |
| Q4 2025 | $67M | +26% |
| Q3 2025 | $93M | +33% |
| Q2 2025 | $23M | -75% |
| Q1 2025 | $5M | +$17M |
| Q4 2024 | $53M | +83% |
PHIN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PHIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -900K shares |
| 1 year | -6.3% | -2.5M shares |
| 3 years | -21% | -10M shares |
PHIN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.2x | Healthy |
PHIN's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PHIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 55.5 | Neutral |
PHIN's weekly RSI is 56 (neutral) and its Stochastic is 55 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PHIN PE vs Consumer Cyclical Sector
| Metric | PHIN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 1 | 35 | 34 pts below |
PHIN is trading at 15x earnings, a 19% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
PHIN has stronger trend alignment. LCID is above 0 of 5 weekly averages versus PHIN above 4 of 4.
PHIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 16% above |
| 20 week MA | $68.6 | 5.6% above |
| 50 week MA | $70.2 | 3.3% above |
| 100 week MA | $59.6 | 22% above |
PHIN is in an uptrend: it's above all four of its weekly moving averages, and 22% above its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PHIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $31.5 | $30.3 | -3.8% |
| 2024 | $30.3 | $48.2 | +59% |
| 2025 | $48.2 | $61.4 | +27% |
| 2026 YTD | $61.4 | $72.5 | +18% |
PHIN has the edge over LCID on returns for 2026, with the stronger performance.